Skip to main content

Peer Review reports

From: A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial

Original Submission
31 Mar 2021 Submitted Original manuscript
6 Apr 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
7 Apr 2021 Editorially accepted
19 Apr 2021 Article published 10.1186/s13063-021-05254-0

You can find further information about peer review here.

Back to article page